You can buy or sell CARA and other stocks, options, ETFs, and crypto commission-free!
CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. Read More The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frédérique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
52 Week High
52 Week Low
-$0.58 per share
-$0.74 per share